PD-1/PD-L1-IN-NP19, a PD-1/PD-L1 inhibitor, exhibits an IC50 of 12.5 nM against the human PD-1/PD-L1 interaction, potentially activating the tumor immune microenvironment and contributing to its antitumor effects[1].
Molecular Weight:
555.06
Purity:
96.70%
CAS Number:
[2377916-66-8]
Formula:
C33H31ClN2O4
Target:
PD-1/PD-L1
T36900
* VAT and and shipping costs not included. Errors and price changes excepted